Biacore s Q4 Revenue Rose 23 percent on US sales Recovery | GenomeWeb

NEW YORK, Feb.24 (GenomeWeb News) - Biacore today said that sales for the fourth quarter rose 23 percent to 193.7 million Swedish kronor ($24.6 million) from 157.1 million Swedish kronor a year ago. Sales in the US rose 48 percent and European sales were up 45 percent, but receipts in Asia-Pacific declined by 20 percent. Biacore posted fourth-quarter net income of 49.4 million Swedish kronor, or 5.06 Swedish kronor per share, versus 24.4 million Swedish kronor, or 2.51 Swedish kronor per share, during the same period last year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.